The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 10, 2020
Filed:
Nov. 30, 2016
Applicants:
Inserm (Institut National DE LA Sante ET DE LA Recherche Medicale), Paris, FR;
Universite Paris-sud, Orsay, FR;
Inventors:
Sylvia Cohen-Kaminsky, Le Plessis Robinson, FR;
Sebastien Dumas, Le Plessis Robinson, FR;
Gilles Bru-Mercier, Le Plessis Robinson, FR;
Assignees:
INSERM (Institut National de la Santé et de la Recherche Médicale), Paris, FR;
Université Paris Sud, Orsay, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/17 (2006.01); A61K 31/135 (2006.01); C12N 15/113 (2010.01); A61K 31/13 (2006.01); A61K 31/445 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01); A61K 31/451 (2006.01); A61K 31/713 (2006.01); A61K 39/395 (2006.01); C07K 16/28 (2006.01); A61K 31/662 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1787 (2013.01); A61K 31/13 (2013.01); A61K 31/135 (2013.01); A61K 31/445 (2013.01); A61K 31/451 (2013.01); A61K 31/662 (2013.01); A61K 31/713 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 16/28 (2013.01); C12N 15/113 (2013.01); A61K 2300/00 (2013.01);
Abstract
The present invention relates to an N-Methyl-D-aspartate (NMDA) receptor antagonist, for use in the treatment of diseases associated with angiogenesis such as tumor angiogenesis, ocular neovascular disease, Age-related macular degeneration (AMD).